MRM Company Profile and Key Details

Q: Who are the executives of MRM?

Mr. Fumitoshi FujiwaraChief Financial Officer & DirectorMr. Kouji EguchiChief Executive Officer & Representative DirectorMr. Akira AokiExecutive Officer & Chief Medical Officer

NASDAQ : MRM

MEDIROM Healthcare Technologies

$1.34

-0.12-8.22%

At Close 4:00 PM

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

MEDIROM Healthcare Technologies Inc. (MRM) stock declined over -8.22%, trading at $1.34 on NASDAQ, down from the previous close of $1.46. The stock opened at $1.42, fluctuating between $1.29 and $1.45 in the recent session.

Stock Snapshot

1.46

Prev. Close

6.84M

Market Cap

1.292

Day Low

3.35

P/E Ratio

0.4

EPS (TTM)

N/A

Cash Flow per Share

1.42

Open

5.11M

Number of Shares

1.45

Day High

73.58%

Free Float in %

N/A

Book Value

78.35K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	1.42	1.43	1.30	1.34	78.44K
Feb 04, 2026	1.42	1.46	1.40	1.46	19.19K
Feb 03, 2026	1.45	1.47	1.40	1.46	32.53K
Feb 02, 2026	1.48	1.49	1.41	1.46	33.33K
Jan 30, 2026	1.57	1.57	1.47	1.48	85.29K
Jan 29, 2026	1.62	1.65	1.50	1.53	64.14K
Jan 28, 2026	1.65	1.67	1.62	1.67	24.17K
Jan 27, 2026	1.62	1.70	1.60	1.67	53.75K
Jan 26, 2026	1.73	1.73	1.60	1.69	167.05K
Jan 23, 2026	1.72	1.72	1.68	1.71	16.7K
Jan 22, 2026	1.71	1.74	1.70	1.73	29.35K
Jan 21, 2026	1.70	1.72	1.67	1.70	36.71K
Jan 20, 2026	1.77	1.78	1.70	1.71	41.06K
Jan 16, 2026	1.73	1.75	1.69	1.75	30.11K
Jan 15, 2026	1.78	1.78	1.74	1.75	19.66K
Jan 14, 2026	1.78	1.84	1.74	1.77	50.79K
Jan 13, 2026	1.88	1.92	1.77	1.80	48.09K
Jan 12, 2026	1.85	1.88	1.81	1.85	21.77K
Jan 09, 2026	1.92	1.94	1.83	1.89	67.61K
Jan 08, 2026	1.88	1.94	1.88	1.93	92.77K

Contact Details

Tokyo, 135-0091

Japan

https://medirom.co.jp 813 672 17364

About Company

MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of December 31, 2021, this segment operated 312 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Stock Peers

FTDR

0.23+0.40%

Frontdoor, Inc.$57.14 RGS

-1.4674-6.37%

Regis Corporation$21.57 WW

-1.26-6.17%

WW International, Inc.$19.15 ROVR

0.005+0.05%

Rover Group, Inc.$11.00 MCW

-0.02-0.34%

Mister Car Wash, Inc.$5.87 EM

0.02+1.75%

Smart Share Global Limited$1.16 EJH

-0.0334-4.67%

E-Home Household Service Holdings Limited$0.68 TRNR

-0.0399-8.87%

Interactive Strength Inc.$0.41 XWEL

0.0192+5.34%

XWELL, Inc.$0.38 YYGH

-0.0198-9.42%

YY Group Holding Limited$0.19

Company Overview

MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) closed at $1.34 USD, losing -$0.12 (-8.22%) from the previous close of $1.46. The stock is currently mid-range between its 52-week high and low $0.34 and $4.45. With a market capitalization of about $6.84 million, MEDIROM Healthcare Technologies Inc. is classified as a micro-cap and shows market-like volatility (beta ~0.97). Key stats such as the average daily volume over the past year has been around 125.72 thousand shares, volume is running light vs its 52-week average. Headquartered in Tokyo, None, MEDIROM Healthcare Technologies Inc. operates in the Consumer Cyclical sector and the Personal Products & Services industry. Led by CEO Kouji Eguchi, the company employs approximately 334 people and listed since December 29, 2020. MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan.

Technical Performance

MRM has shown weak momentum, losing -7.57% over the past week and -29.92% over the past quarter, though year-to-date performance is down -11.86%. Short-term trend indicators are mixed aligned (SMA20 -19.63%, SMA50 -30.04%, SMA200 -22.05%). The stock’s 14-day RSI is 16.44 (weak momentum), while the ATR of 0.1 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -69.89% below its high and over 293.77% above its low. Average 10-day trading volume of 61.99 thousand shares is in line with the 3-month average of 62.45 thousand, indicating normal recent market interest.

Valuation Metrics

MEDIROM Healthcare Technologies Inc. trades at a P/E ratio of 0.01, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 3.33 trading at moderately above to book value. The P/FCF stands at -0.01, also below market averages.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Earnings & Analyst Outlook

MEDIROM Healthcare Technologies Inc. generated EPS of $0.37 over the past year. Five-year average earnings growth is 33.55%.

Shareholding & Insider Activity

MEDIROM Healthcare Technologies Inc. has 7.90 million shares outstanding. The public float is 5.81 million shares, elevated short interest at 0.06% of float. This equals 3.84 thousand shares. The short ratio is 0.17 days. Institutional investors hold 1.94% of the float. Insiders own 26.42%.

Financial & Profitability Overview

Over the trailing twelve months, MEDIROM Healthcare Technologies generated $6.95B in revenue, or $1.27K per share. Gross margin was 27.36%, operating margin 2.51%, and net profit margin 2.14%. Returns are negative, with ROA at 2.21% and ROE at -250.88%.
On valuation metrics, MEDIROM Healthcare Technologies trades at a P/E of 0.01, P/S of 0.00 and P/B of 3.33. Liquidity is tight, with a current ratio of 0.24 and quick ratio of 0.21. Operationally, the company’s inventory turnover is 2617.23 and cash conversion cycle is -0.64 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 8.84, supported by a cash flow-to-debt ratio of -20.22.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2022, MEDIROM Healthcare Technologies posted revenue of $6.95B, down slightly from $5.41B in the prior quarter. Gross profit was $1.90B (margin 27.36%). Operating income was $174.74M (margin 2.5%). Net income was$148.97M (EPS $30.54).
The company ended the quarter with $631.95M in cash and short-term investments, a total debt of $3.23B, and net debt of $2.63B. Total assets were $6.75B, with equity of - $59.38M. Financials further reflected weakness, with operating cash flow of - $685.70M, free cash flow of - $852.20M, and capital expenditures of - $166.50M.

Price Forecast & Outlook

Our AI price prediction model suggests that MEDIROM Healthcare Technologies Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.72%, with price expected at $1.25 by February 18, 2026, within a range of $1.18 to $1.31 3-Month Outlook: Projected fall of -61.19%, reaching $0.52 by May 05, 2026, with a range of $0.35 to $0.65. 1-Year Outlook: Projected gain of 493.28%, with price at $7.95 by February 04, 2027, within a range of $4.99 to $10.62.

Key Takeaways

MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) shares are down -11.86% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows MEDIROM Healthcare Technologies Inc. trading at a premium to the broader market with a P/E of 0.01. Our AI forecast model points to short-term weakness (-6.72% over two weeks), a medium-term fall (-61.19% over three months), and a longer-term gain (493.28% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current MEDIROM Healthcare Technologies Inc. (MRM) stock price?

MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) stock price is $1.34 in the last trading session. During the trading session, MRM stock reached the peak price of $1.45 while $1.29 was the lowest point it dropped to. The percentage change in MRM stock occurred in the recent session was -8.22% while the dollar amount for the price change in MRM stock was - $0.12.

MRM's industry and sector of operation?

The NASDAQ listed MRM is part of Personal Products & Services industry that operates in the broader Consumer Cyclical sector. MEDIROM Healthcare Technologies Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MRM?

Mr. Fumitoshi Fujiwara
Chief Financial Officer & Director
Mr. Kouji Eguchi
Chief Executive Officer & Representative Director
Mr. Akira Aoki
Executive Officer & Chief Medical Officer

How MRM did perform over past 52-week?

MRM's closing price is 294.12% higher than its 52-week low of $0.34 where as its distance from 52-week high of $4.45 is -69.89%.

How many employees does MRM have?

Number of MRM employees currently stands at 334.

Link for MRM official website?

Official Website of MRM is: https://medirom.co.jp

How do I contact MRM?

MRM could be contacted at phone 813 672 17364 and can also be accessed through its website. MRM operates from Tradepia Odaiba, Tokyo, 135-0091, Japan.

How many shares of MRM are traded daily?

MRM stock volume for the day was 78.35K shares. The average number of MRM shares traded daily for last 3 months was 125.72K.

What is the market cap of MRM currently?

The market value of MRM currently stands at $6.84M with its latest stock price at $1.34 and 5.11M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	334
Beta	0.95
Sales or Revenue	$6.95B
5Y Sales Change%	0.818%
Fiscal Year Ends	December
Sector	Consumer Cyclical
Industry	Personal Products & Services

MRM Company Profile and Key Details

MEDIROM Healthcare Technologies

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook

Valuation Metrics